You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 135 No. 6, June 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (20)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Patient Safety/ Medical Error
 •Alert me on articles by topic

Ivermectin

A New Therapeutic Weapon in Dermatology?

Arch Dermatol. 1999;135:705-706.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

IVERMECTIN IS a semisynthetic derivative of a family of macrocyclic lactones: the avermectins. These compounds have an antiparasitic effect, inducing paralysis in arthropods and nematodes by interruption of {gamma}-aminobutyric acid–induced neurotransmission.1 This drug has been used extensively for the control of a wide variety of parasites in farm and domestic animals.1-2 In humans, ivermectin has been used extensively since 1987 to control onchocerciasis in countries of Africa and Latin America, where the disease is endemic. The drug is also effective in the treatment of other filariases such as loiasis and bancroftian filariasis and other intestinal nematodes, mainly strongyloidiasis.2 The interest of dermatologists in ivermectin grew as it became evident that some parasitic infections in humans with cutaneous tropism could easily and successfully be treated with the drug either orally or topically.3 Indeed the most promising results have been shown in the treatment of cutaneous parasitosis caused by nematodes such as . . . [Full Text of this Article]


RELATED ARTICLE

Equivalent Therapeutic Efficacy and Safety of Ivermectin and Lindane in the Treatment of Human Scabies
Edgardo N. Chouela, Alejandra M. Abeldaño, Graciela Pellerano, Marta La Forgia, Rosa María Papale, Armando Garsd, María del Carmen Balian, Viviana Battista, and Nora Poggio
Arch Dermatol. 1999;135(6):651-655.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ivermectin: A Few Caveats Are Warranted Before Initiating Therapy for Scabies
Burkhart and Burkhart
Arch Dermatol 1999;135:1549-1550.
FULL TEXT  

Ivermectin for Scabies
Altman
Arch Dermatol 1999;135:1550-1550.
FULL TEXT  

Oral Ivermectin for Scabies?
JWatch General 1999;1999:4-4.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.